Pulmonary arteriovenous malformation (PAVM) is a rare anomalous direct communication between the pulmonary artery and vein with a considerable risk of serious complications such as cerebral thromboembolism or abscess and pulmonary hemorrhage. Although the past, surgical resection such as lobectomy was mostly used to treat PAVM, the recent development of endovascular treatment has made it a primary consideration to perform transcatheter embolization using coils or detachable balloons. We report a case of successful transcatheter embolization of giant PAVM with the second generation Amplatzer vascular plug II as a new self-expanding device. 
Pulmonary arteriovenous malformation (PAVM) is a rare anomalous direct communication between the pulmonary artery and vein with a considerable risk of serious complications such as cerebral thromboembolism or abscess and pulmonary hemorrhage. Although the past, surgical resection such as lobectomy was mostly used to treat PAVM, the recent development of endovascular treatment has made it a primary consideration to perform transcatheter embolization using coils or detachable balloons. We report a case of successful transcatheter embolization of giant PAVM with the second generation Amplatzer vascular plug II as a new self-expanding device. (Fig. 1 ).
Because use of coil embolic device in the existing PAVM had a high likehood of complications including device migration, we decided to perform transcatheter embolization using (Fig. 2 ). There were no procedure related complications and there was marked improvement of patient's symptoms. Chest CT scan at three years-follow-up showed nearly complete regression of pulmonary arteriovenous malformation and complete occlusion of the fistula (Fig. 3) .
DISCUSSION
About 80% of PAVM are congenital. Acquired PAVM is related to injury, mitral stenosis, or actinomycosis caused by chest trauma or chest surgery [1] [2] [3] . Among congenital cases, about 50% to 80% are associated with Osler-Weber-Render syndrome or hereditary hemorrhagic telangiectasia. Our case was assumed to be congenital PAVM without any apparent acquired origin, although there were no abnormalities in skin, oral, and nasal mucosa. About 13% to 15% of PAVM show symptoms such as dyspnea, hemoptysis, or hemothorax related to the intrapulmonary arteriovenous shunt [4, 5] . In cases with severe symptomatologies, hemorrhage from a ruptured PAVM and various neurological complications such as cerebrovascular accidents from brain abscess and paradoxical embolism may occur [2, 6] .
In the past, surgical removal through ligation, segmentectomy, lobectomy, and pneumonectomy, among others, was the first approach used. However, because of high surgery-related morbidity and mortality, endovascular embolization with coil or balloon is currently preferred [7, 8] . In this case study, the diameter of the feeding artery was about 7 mm and sac diameter was 30 mm which would be associated with high Minimum size of the guiding catheter is 5F and detachment can be done with a counterclockwise rotation of the pusher wire after deployment. In oversizing of the device, the company recommends a 20% larger diameter than that of the target vessel, but as seen in this case study, that also depends on the patient's target vessel and anatomy vessel such as a pulmonary feeding artery.
From our case, we suggest that transcatheter embolization with AVP II might be a reasonable alternative in the treatment of PAVM because of its effectiveness and ease of device management.
